Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Senestech, Inc. (SNES : NSDQ)
 
 • Company Description   
SenesTech, Inc. developed technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's fertility control product candidate, ContraPest(R), will be marketed for use initially in controlling rat infestations. SenesTech, Inc. is based in Flagstaff, Arizona.

Number of Employees: 23

 
 • Price / Volume Information   
Yesterday's Closing Price: $5.09 Daily Weekly Monthly
20 Day Moving Average: 246,768 shares
Shares Outstanding: 2.02 (millions)
Market Capitalization: $10.26 (millions)
Beta: 0.17
52 Week High: $6.48
52 Week Low: $1.30
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 81.14% 73.29%
12 Week 271.56% 203.13%
Year To Date 53.78% 45.76%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
13430 North Dysart Road Suite 105
-
Surprise,AZ 85379
USA
ph: 928-779-4143
fax: -
senestech@lythampartners.com http://www.senseonics.com
 
 • General Corporate Information   
Officers
Joel Fruendt - President and Chief Executive Officer
Jamie Bechtel - Chair of the Board
Thomas C. Chesterman - Executive Vice President; Chief Financial Officer;
Phil Grandinetti - Director
Jake Leach - Director

Peer Information
Senestech, Inc. (BJCT)
Senestech, Inc. (CADMQ)
Senestech, Inc. (APNO)
Senestech, Inc. (UPDC)
Senestech, Inc. (IMTIQ)
Senestech, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 81720R604
SIC: 2870
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25
Share - Related Items
Shares Outstanding: 2.02
Most Recent Split Date: 7.00 (0.10:1)
Beta: 0.17
Market Capitalization: $10.26 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-6.24 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/14/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.13
Price/Cash Flow: -
Price / Sales: 5.32
EPS Growth
vs. Year Ago Period: 64.44%
vs. Previous Quarter: -4.92%
Sales Growth
vs. Year Ago Period: 16.87%
vs. Previous Quarter: -3.19%
ROE
06/30/25 - -
03/31/25 - -197.80
12/31/24 - -178.14
ROA
06/30/25 - -
03/31/25 - -156.39
12/31/24 - -143.51
Current Ratio
06/30/25 - -
03/31/25 - 5.83
12/31/24 - 5.01
Quick Ratio
06/30/25 - -
03/31/25 - 4.44
12/31/24 - 3.60
Operating Margin
06/30/25 - -
03/31/25 - -312.25
12/31/24 - -333.01
Net Margin
06/30/25 - -
03/31/25 - -312.25
12/31/24 - -333.01
Pre-Tax Margin
06/30/25 - -
03/31/25 - -312.25
12/31/24 - -333.01
Book Value
06/30/25 - -
03/31/25 - 1.63
12/31/24 - 2.42
Inventory Turnover
06/30/25 - -
03/31/25 - 0.90
12/31/24 - 0.99
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.07
12/31/24 - 0.08
Debt-to-Capital
06/30/25 - -
03/31/25 - 6.20
12/31/24 - 7.58
 

Powered by Zacks Investment Research ©